Centralny Szpital Kliniczny - Uniwersyteckie Centrum Kliniczne WUM

Warsaw 02-097

3 studies enrolling now · 3 studies all time

What they study most

Generalized Myasthenia Gravis, gMG

Studies at this site

• A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis — Recruiting now
• Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis — Recruiting now
• Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis — Enrolling by invitation